Order Article Reprints

Zobel-Roos S, Schmidt A, Mestmäcker F, Mouellef M, Huter M, Uhlenbrock L, Kornecki M, Lohmann L, Ditz R, Strube J. Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable without a Digital-Twin? Processes. 2019; 7(2):94. https://doi.org/10.3390/pr7020094

Zobel-Roos, Steffen, Axel Schmidt, Fabian Mestmäcker, Mourad Mouellef, Maximilian Huter, Lukas Uhlenbrock, Martin Kornecki, Lara Lohmann, Reinhard Ditz, and Jochen Strube. 2019. "Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable without a Digital-Twin?" Processes 7, no. 2: 94. https://doi.org/10.3390/pr7020094

Zobel-Roos, S., Schmidt, A., Mestmäcker, F., Mouellef, M., Huter, M., Uhlenbrock, L., Kornecki, M., Lohmann, L., Ditz, R., & Strube, J. (2019). Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable without a Digital-Twin? Processes, 7(2), 94. https://doi.org/10.3390/pr7020094